advanced pancreatic cancer
Conditions
Interventions
From Jan/21/2011 to Feb/28/2015 medicine:GSK cocktail is taken every day together with standard gemcitabine drip infusion therapy (once a week for 3 weeks and one week rest)
Sponsors
1)Multidisciplinary Cancer Center,Kanazawa Medical University Hospital 2)Department of Surgical Oncology, Kanazawa Medical University Hospital
1)Division of Translational and Clinical Oncology, Cancer Research Institute,Kanazawa University 2)Department of Neurosurgery, Kanazawa University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) The age is between 15 and 90 years old. 2) Diagnosis of pancreatic cancer is confirmed by imaging studies, and its clinical stage is advanced. 3) There is no allergy to the drugs used. 4) An appropriate organ function is preserved. 5) There is no condition in which oral administration of drugs is hindered. 6) Informed consent as a document is obtained from the patient or his/her family before enrollment.
Exclusion criteria
Exclusion criteria: 1) A patient who has a past history of hypersensitivity to the medicines used. 2) A pregnant woman, a woman of possible pregnancy, or a lactating woman 3) Miscellaneous patients who are judged inadequate for enrollment by an attending physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| safety | — |
Secondary
| Measure | Time frame |
|---|---|
| Response rate | — |
Countries
Japan
Contacts
Public ContactTakeo Shimasaki
Kanazawa Medical University Hospital Gastroenterology
Outcome results
None listed